European Union · Record · TJ
CELEX 62023TJ0257
Judgment of the General Court (Fourth Chamber) of 24 September 2025.#Neuraxpharm Pharmaceuticals SL v European Commission.#Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU.#Case T-257/23.
Introduced
24 September 2025
Last action
—
Status
decided
Sponsors
—
Subjects
Discovery layer
Source updated
24 September 2025
Records
Official record CELEX 62023TJ0257 from European Union at Court of Justice of the European Union. Dated 24 September 2025. Status: decided.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
23 official files
Judgment of the General Court (Fourth Chamber) of 24 September 2025.#Neuraxpharm Pharmaceuticals SL v European Commission.#Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU.#Case T-257/23.
Judgment of the General Court (Fourth Chamber) of 24 September 2025.#Neuraxpharm Pharmaceuticals SL v European Commission.#Medicinal products for human use – Variation of the marketing authorisation for Tecfidera – Dimethyl fumarate, a medicinal product for human use – Directive 2001/83/EC – Article 14(11) of Regulation (EC) No 726/2004 – Article 266 TFEU.#Case T-257/23.
judgment · EN · 24 September 2025
Tribunalens dom (fjärde avdelningen) av den 24 september 2025.#Neuraxpharm Pharmaceuticals SL mot Europeiska kommissionen.#Mål T-257/23.
judgment · SV · 24 September 2025
Sodba Splošnega sodišča (četrti senat) z dne 24. septembra 2025.#Neuraxpharm Pharmaceuticals SL proti Evropski komisiji.#Zdravila za uporabo v humani medicini – Sprememba dovoljenja za promet z zdravilom za uporabo v humani medicini Tecfidera – dimetil fumarat – Direktiva 2001/83/ES – Člen 14(11) Uredbe (ES) št. 726/2004 – Člen 266 PDEU.#Zadeva T-257/23.
judgment · SL · 24 September 2025
Rozsudok Všeobecného súdu (štvrtá komora) z 24. septembra 2025.#Neuraxpharm Pharmaceuticals SL proti Európskej komisii.#Vec T-257/23.
judgment · SK · 24 September 2025
Hotărârea Tribunalului (Camera a patra) din 24 septembrie 2025.#Neuraxpharm Pharmaceuticals SL împotriva Comisiei Europene.#Cauza T-257/23.
judgment · RO · 24 September 2025
Acórdão do Tribunal Geral (Quarta Secção) de 24 de setembro de 2025.#Neuraxpharm Pharmaceuticals SL contra Comissão Europeia.#Processo T-257/23.
judgment · PT · 24 September 2025
Wyrok Sądu (czwarta izba) z dnia 24 września 2025 r.#Neuraxpharm Pharmaceuticals SL przeciwko Komisji Europejskiej.#Sprawa T-257/23.
judgment · PL · 24 September 2025
Arrest van het Gerecht (Vierde kamer) van 24 september 2025.#Neuraxpharm Pharmaceuticals SL tegen Europese Commissie.#Geneesmiddelen voor menselijk gebruik – Wijziging van de vergunning voor het in de handel brengen van het geneesmiddel voor menselijk gebruik Tecfidera – dimethylfumaraat – Richtlijn 2001/83/EG – Artikel 14, lid 11, van verordening (EG) nr. 726/2004 – Artikel 266 VWEU.#Zaak T-257/23.
judgment · NL · 24 September 2025
Sentenza tal-Qorti Ġenerali (Ir-Raba’ Awla) tal-24 ta’ Settembru 2025.#Neuraxpharm Pharmaceuticals SL vs Il-Kummissjoni Ewropea.#Prodotti mediċinali għall-użu mill-bniedem – Emenda tal-awtorizzazzjoni għat-tqegħid fis-suq tal-prodott mediċinali għall-użu mill-bniedem Tecfidera — Dimetil fumarat – Direttiva 2001/83/KE – Artikolu 14(11) tar-Regolament (KE) Nru 726/2004 – Artikolu 266 TFUE.#Kawża T-257/23.
judgment · MT · 24 September 2025
Vispārējās tiesas spriedums (ceturtā palāta), 2025. gada 24. septembris.#Neuraxpharm Pharmaceuticals SL pret Eiropas Komisiju.#Cilvēkiem paredzētas zāles – Cilvēkiem paredzētu zāļu “Tecfidera – dimetilfumarāts” tirdzniecības atļaujas grozījumi – Direktīva 2001/83/EK – Regulas (EK) Nr. 726/2004 14. panta 11. punkts – LESD 266. pants.#Lieta T-257/23.
judgment · LV · 24 September 2025
2025 m. rugsėjo 24 d. Bendrojo Teismo (ketvirtoji kolegija) sprendimas.#Neuraxpharm Pharmaceuticals SL prieš Europos Komisiją.#Žmonėms skirti vaistai – Žmonėms skirto vaisto „Tecfidera – dimetilfumaratas rinkodaros leidimo pakeitimas – Direktyva 2001/83/EB – Reglamento (EB) Nr. 726/2004 14 straipsnio 11 dalis – SESV 266 straipsnis.#Byla T-257/23.
judgment · LT · 24 September 2025
Sentenza del Tribunale (Quarta Sezione) del 24 settembre 2025.#Neuraxpharm Pharmaceuticals SL contro Commissione europea.#Causa T-257/23.
judgment · IT · 24 September 2025
A Törvényszék ítélete (negyedik tanács), 2025. szeptember 24.#Neuraxpharm Pharmaceuticals SL kontra Európai Bizottság.#T-257/23. sz. ügy.
judgment · HU · 24 September 2025
Presuda Općeg suda (četvrto vijeće) od 24. rujna 2025.#Neuraxpharm Pharmaceuticals SL protiv Europske komisije.#Predmet T-257/23.
judgment · HR · 24 September 2025
Unionin yleisen tuomioistuimen tuomio (neljäs jaosto) 24.9.2025.#Neuraxpharm Pharmaceuticals SL vastaan Euroopan komissio.#Ihmisille tarkoitetut lääkkeet – Ihmisille tarkoitetun lääkkeen Tecfidera - dimetyylifumaraatti myyntiluvan muuttaminen – Direktiivi 2001/83/EY – Asetuksen (EY) N:o 726/2004 14 artiklan 11 kohta – SEUT 266 artikla.#Asia T-257/23.
judgment · FI · 24 September 2025
Üldkohtu otsus (neljas koda), 24.9.2025.#Neuraxpharm Pharmaceuticals SL versus Euroopa Komisjon.#Inimtervishoius kasutatavad ravimid – Inimtervishoius kasutatava ravimi Tecfidera - dimetüülfumaraat müügiloa muutmine – Direktiiv 2001/83/EÜ – Määruse (EÜ) nr 726/2004 artikli 14 lõige 11 – ELTL artikkel 266.#Kohtuasi T-257/23.
judgment · ET · 24 September 2025
Sentencia del Tribunal General (Sala Cuarta) de 24 de septiembre de 2025.#Neuraxpharm Pharmaceuticals, S. L., contra Comisión Europea.#Medicamentos para uso humano — Modificación de la autorización de comercialización del medicamento para uso humano Tecfidera — dimetilfumarato — Directiva 2001/83/CE — Artículo 14, apartado 11, del Reglamento (CE) n.º 726/2004 — Artículo 266 TFUE.#Asunto T-257/23.
judgment · ES · 24 September 2025
Απόφαση του Γενικού Δικαστηρίου (τέταρτο τμήμα) της 24ης Σεπτεμβρίου 2025.#Neuraxpharm Pharmaceuticals SL κατά Ευρωπαϊκής Επιτροπής.#Φάρμακα που προορίζονται για ανθρώπινη χρήση – Τροποποίηση της άδειας κυκλοφορίας του φαρμάκου για ανθρώπινη χρήση Tecfidera – φουμαρικός διμεθυλεστέρας – Οδηγία 2001/83/ΕΚ – Άρθρο 14, παράγραφος 11, του κανονισμού (ΕΚ) 726/2004 – Άρθρο 266 ΣΛΕΕ.#Υπόθεση T-257/23.
judgment · EL · 24 September 2025
Urteil des Gerichts (Vierte Kammer) vom 24. September 2025.#Neuraxpharm Pharmaceuticals SL gegen Europäische Kommission.#Rechtssache T-257/23.
judgment · DE · 24 September 2025
Rettens dom (Fjerde Afdeling) af 24. september 2025.#Neuraxpharm Pharmaceuticals SL mod Europa-Kommissionen.#Sag T-257/23.
judgment · DA · 24 September 2025
Rozsudek Tribunálu (čtvrtého senátu) ze dne 24. září 2025.#Neuraxpharm Pharmaceuticals SL v. Evropská komise.#Věc T-257/23.
judgment · CS · 24 September 2025
Решение на Общия съд (четвърти състав) от 24 септември 2025 г.#Neuraxpharm Pharmaceuticals SL срещу Европейска комисия.#Дело T-257/23.
judgment · BG · 24 September 2025
Arrêt du Tribunal (quatrième chambre) du 24 septembre 2025.#Neuraxpharm Pharmaceuticals SL contre Commission européenne.#Médicaments à usage humain – Modification de l’autorisation de mise sur le marché du médicament à usage humain Tecfidera – diméthyle fumarate – Directive 2001/83/CE – Article 14, paragraphe 11, du règlement (CE) no 726/2004 – Article 266 TFUE.#Affaire T-257/23.
judgment · FR · 24 September 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.